These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26865711)

  • 1. Hepatitis B Virus Infection of a Mouse Hepatic Cell Line Reconstituted with Human Sodium Taurocholate Cotransporting Polypeptide.
    Lempp FA; Qu B; Wang YX; Urban S
    J Virol; 2016 May; 90(9):4827-4831. PubMed ID: 26865711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocytic expression of human sodium-taurocholate cotransporting polypeptide enables hepatitis B virus infection of macaques.
    Burwitz BJ; Wettengel JM; Mück-Häusl MA; Ringelhan M; Ko C; Festag MM; Hammond KB; Northrup M; Bimber BN; Jacob T; Reed JS; Norris R; Park B; Moller-Tank S; Esser K; Greene JM; Wu HL; Abdulhaqq S; Webb G; Sutton WF; Klug A; Swanson T; Legasse AW; Vu TQ; Asokan A; Haigwood NL; Protzer U; Sacha JB
    Nat Commun; 2017 Dec; 8(1):2146. PubMed ID: 29247188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide.
    Yan H; Peng B; Liu Y; Xu G; He W; Ren B; Jing Z; Sui J; Li W
    J Virol; 2014 Mar; 88(6):3273-84. PubMed ID: 24390325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium taurocholate cotransporting polypeptide is the limiting host factor of hepatitis B virus infection in macaque and pig hepatocytes.
    Lempp FA; Wiedtke E; Qu B; Roques P; Chemin I; Vondran FWR; Le Grand R; Grimm D; Urban S
    Hepatology; 2017 Sep; 66(3):703-716. PubMed ID: 28195359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis B Virus Infection of HepaRG Cells, HepaRG-hNTCP Cells, and Primary Human Hepatocytes.
    Ni Y; Urban S
    Methods Mol Biol; 2017; 1540():15-25. PubMed ID: 27975304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium taurocholate cotransporting polypeptide inhibition efficiently blocks hepatitis B virus spread in mice with a humanized liver.
    Nakabori T; Hikita H; Murai K; Nozaki Y; Kai Y; Makino Y; Saito Y; Tanaka S; Wada H; Eguchi H; Takahashi T; Suemizu H; Sakamori R; Hiramatsu N; Tatsumi T; Takehara T
    Sci Rep; 2016 Jun; 6():27782. PubMed ID: 27278060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that hepatitis B virus replication in mouse cells is limited by the lack of a host cell dependency factor.
    Lempp FA; Mutz P; Lipps C; Wirth D; Bartenschlager R; Urban S
    J Hepatol; 2016 Mar; 64(3):556-64. PubMed ID: 26576481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of retinoic acid receptor diminishes hepatocyte permissiveness to hepatitis B virus infection through modulation of sodium taurocholate cotransporting polypeptide (NTCP) expression.
    Tsukuda S; Watashi K; Iwamoto M; Suzuki R; Aizaki H; Okada M; Sugiyama M; Kojima S; Tanaka Y; Mizokami M; Li J; Tong S; Wakita T
    J Biol Chem; 2015 Feb; 290(9):5673-84. PubMed ID: 25550158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Robust Human and Murine Hepatocyte Culture Models of Hepatitis B Virus Infection and Replication.
    Qiao L; Sui J; Luo G
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30232184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HBV life cycle is restricted in mouse hepatocytes expressing human NTCP.
    Li H; Zhuang Q; Wang Y; Zhang T; Zhao J; Zhang Y; Zhang J; Lin Y; Yuan Q; Xia N; Han J
    Cell Mol Immunol; 2014 Mar; 11(2):175-83. PubMed ID: 24509445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of cell membrane localized NTCP expression in proliferating hepatocytes prevents hepatitis B virus infection.
    Yan Y; Allweiss L; Yang D; Kang J; Wang J; Qian X; Zhang T; Liu H; Wang L; Liu S; Sui J; Chen X; Dandri M; Zhao J; Lu F
    Emerg Microbes Infect; 2019; 8(1):879-894. PubMed ID: 31179847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Woodchuck sodium taurocholate cotransporting polypeptide supports low-level hepatitis B and D virus entry.
    Fu L; Hu H; Liu Y; Jing Z; Li W
    Virology; 2017 May; 505():1-11. PubMed ID: 28213271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis D Virus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide.
    He W; Ren B; Mao F; Jing Z; Li Y; Liu Y; Peng B; Yan H; Qi Y; Sun Y; Guo JT; Sui J; Wang F; Li W
    PLoS Pathog; 2015 Apr; 11(4):e1004840. PubMed ID: 25902143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human induced pluripotent stem cell-derived hepatic cell lines as a new model for host interaction with hepatitis B virus.
    Kaneko S; Kakinuma S; Asahina Y; Kamiya A; Miyoshi M; Tsunoda T; Nitta S; Asano Y; Nagata H; Otani S; Kawai-Kitahata F; Murakawa M; Itsui Y; Nakagawa M; Azuma S; Nakauchi H; Nishitsuji H; Ujino S; Shimotohno K; Iwamoto M; Watashi K; Wakita T; Watanabe M
    Sci Rep; 2016 Jul; 6():29358. PubMed ID: 27386799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide.
    Kaneko M; Watashi K; Kamisuki S; Matsunaga H; Iwamoto M; Kawai F; Ohashi H; Tsukuda S; Shimura S; Suzuki R; Aizaki H; Sugiyama M; Park SY; Ito T; Ohtani N; Sugawara F; Tanaka Y; Mizokami M; Sureau C; Wakita T
    J Virol; 2015 Dec; 89(23):11945-53. PubMed ID: 26378168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Bouezzedine F; Fardel O; Gripon P
    Virology; 2015 Jul; 481():34-42. PubMed ID: 25765005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of the hepatic bile acid uptake transporter and HBV entry receptor NTCP.
    Appelman MD; Wettengel JM; Protzer U; Oude Elferink RPJ; van de Graaf SFJ
    Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Aug; 1866(8):158960. PubMed ID: 33932583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.
    Yan H; Zhong G; Xu G; He W; Jing Z; Gao Z; Huang Y; Qi Y; Peng B; Wang H; Fu L; Song M; Chen P; Gao W; Ren B; Sun Y; Cai T; Feng X; Sui J; Li W
    Elife; 2012 Nov; 3():. PubMed ID: 25409679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.